prednisone. Medications that block the action of interleukin-1, such as anakinra, can be effective treatments when standard steroid treatments are insufficient... 17 KB (1,698 words) - 05:59, 4 May 2024 |
considered an autoinflammatory disorder and is generally treated with anakinra, which inhibits interleukin 1. This treatment controls the condition but... 11 KB (1,149 words) - 08:30, 28 March 2024 |
Treatment with either glucocorticoids, methotrexate, anakinra, or tocilizumab has been examined. Anakinra has been shown to resolve the clinical features of... 10 KB (1,043 words) - 13:17, 3 December 2023 |
can be used to reduce the effects of the disorder. Anakinra is antagonist to IL-1 receptors. Anakinra binds the IL-1 receptor, preventing the actions of... 17 KB (1,889 words) - 07:13, 15 April 2024 |
it. It should not be used in combination with anakinra or TNF antagonists. Because abatacept, anakinra, and TNF antagonists suppress the immune system... 9 KB (905 words) - 04:10, 31 January 2024 |
cases are resistant to colchicine therapy alone. In these cases, adding anakinra to the daily colchicine regimen has been successful. Canakinumab, an... 26 KB (2,644 words) - 16:56, 1 May 2024 |
COVID-19 drug repurposing research (section Anakinra) ventilation, or extracorporeal membrane oxygenation. In December 2021, anakinra (Kineret) was authorized in the European Union for the treatment of COVID-19... 126 KB (14,697 words) - 14:55, 5 May 2024 |
action of interleukin 1; they cannot be taken in tablet form. These are anakinra, canakinumab and rilonacept. Rilonacept has been specifically approved... 27 KB (2,367 words) - 11:10, 18 April 2024 |
the first female rabbi in Israel Kineret (medication), brand name of anakinra; no direct relation to the lake Kinneret, Israeli song based on Rachel... 1 KB (236 words) - 07:29, 13 December 2023 |
Agonists: Interleukin 1 (α, β) Mobenakin Pifonakin Antagonists: AF-12198 Anakinra IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy... 22 KB (1,841 words) - 22:50, 30 April 2024 |
IL-1 receptor antagonists Anakinra mTOR Sirolimus Everolimus Ridaforolimus Temsirolimus Umirolimus Zotarolimus... 7 KB (299 words) - 13:45, 27 April 2024 |
IL-1β has become a common therapeutic target, and medications such as anakinra, rilonacept, and canakinumab have revolutionized the treatment of autoinflammatory... 9 KB (789 words) - 14:23, 1 December 2023 |
number of new medications are under study for treating gout, including anakinra, canakinumab, and rilonacept. Canakinumab may result in better outcomes... 77 KB (7,829 words) - 19:10, 2 May 2024 |
In refractory cases treatment regimens are used similar to that in HLH. Anakinra is also effective. Cytokine release syndrome Grom AA, Mellins ED (September... 5 KB (534 words) - 13:21, 3 December 2023 |
gene in gene therapy) against heart aging (13 Jan), mice-tested in-use anakinra (or blockade of its target IL-1β) against haematopoietic blood aging (17... 324 KB (28,839 words) - 08:57, 22 April 2024 |
Administration. 27 May 2009. Archived from the original on 20 August 2009. "Anakinra (Kineret) to be deleted from the PBS". National Prescribing Service Limited... 42 KB (3,592 words) - 04:40, 30 April 2024 |
marrow. A 2023 study reported that the existing rheumatoid arthritis drug anakinra blocked IL-1B in elderly mice and returned those cells to a more youthful... 16 KB (1,725 words) - 22:58, 9 April 2024 |
Golimumab L04AB07 Opinercept L04AC01 Daclizumab L04AC02 Basiliximab L04AC03 Anakinra L04AC04 Rilonacept L04AC05 Ustekinumab L04AC07 Tocilizumab L04AC08 Canakinumab... 3 KB (367 words) - 15:37, 25 January 2024 |